BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martínez-Navarro M, Maldonado R, Baños JE. Why mu-opioid agonists have less analgesic efficacy in neuropathic pain? Eur J Pain 2019;23:435-54. [PMID: 30318675 DOI: 10.1002/ejp.1328] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Hiroki T, Suto T, Ohta J, Saito S, Obata H. Spinal γ-Aminobutyric Acid Interneuron Plasticity Is Involved in the Reduced Analgesic Effects of Morphine on Neuropathic Pain. J Pain 2022;23:547-57. [PMID: 34678470 DOI: 10.1016/j.jpain.2021.10.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Vincenzi M, Milella MS, D’ottavio G, Caprioli D, Reverte I, Maftei D. Targeting Chemokines and Chemokine GPCRs to Enhance Strong Opioid Efficacy in Neuropathic Pain. Life 2022;12:398. [DOI: 10.3390/life12030398] [Reference Citation Analysis]
3 Du F, Cao R, Chen L, Sun J, Shi Y, Fu Y, Hammock BD, Zheng Z, Liu Z, Chen G. Structure-guided discovery of potent and oral soluble epoxide hydrolase inhibitors for the treatment of neuropathic pain. Acta Pharm Sin B 2022;12:1377-89. [PMID: 35530144 DOI: 10.1016/j.apsb.2021.09.018] [Reference Citation Analysis]
4 Wang X, Bao C, Li Z, Yue L, Hu L. Side Effects of Opioids Are Ameliorated by Regulating TRPV1 Receptors. Int J Environ Res Public Health 2022;19:2387. [PMID: 35206575 DOI: 10.3390/ijerph19042387] [Reference Citation Analysis]
5 Sun N, Yu L, Gao Y, Ma L, Ren J, Liu Y, Gao DS, Xie C, Wu Y, Wang L, Hong J, Yan M. MeCP2 Epigenetic Silencing of Oprm1 Gene in Primary Sensory Neurons Under Neuropathic Pain Conditions. Front Neurosci 2021;15:743207. [PMID: 34803588 DOI: 10.3389/fnins.2021.743207] [Reference Citation Analysis]
6 Inan S, Chen X, Eisenstein EM, Meissler JJ, Geller EB, Tallarida C, Watson M, Doura M, Barrett JE, Cowan A, Rawls SM, Adler MW, Eisenstein TK. Chemokine receptor antagonists enhance morphine's antinociceptive effect but not respiratory depression. Life Sci 2021;285:120014. [PMID: 34619167 DOI: 10.1016/j.lfs.2021.120014] [Reference Citation Analysis]
7 Fidilio A, Grasso M, Turnaturi R, Caruso G, Spitale FM, Vicario N, Parenti R, Spoto S, Musso N, Marrazzo A, Chiechio S, Caraci F, Pasquinucci L, Parenti C. The Multimodal MOPr/DOPr Agonist LP2 Reduces Allodynia in Chronic Constriction Injured Rats by Rescue of TGF-β1 Signalling. Front Pharmacol 2021;12:749365. [PMID: 34690781 DOI: 10.3389/fphar.2021.749365] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
8 Hines CB, Owings CR. Opioids: Understanding How Acute Actions Impact Chronic Consequences. Dimens Crit Care Nurs 2021;40:268-74. [PMID: 34398562 DOI: 10.1097/DCC.0000000000000487] [Reference Citation Analysis]
9 García M, Llorente V, Garriga L, Christmann U, Rodríguez-Escrich S, Virgili M, Fernández B, Bordas M, Ayet E, Burgueño J, Pujol M, Dordal A, Portillo-Salido E, Gris G, Vela JM, Almansa C. Propionamide Derivatives as Dual μ-Opioid Receptor Agonists and σ1 Receptor Antagonists for the Treatment of Pain. J Med Chem 2021;64:10139-54. [PMID: 34236190 DOI: 10.1021/acs.jmedchem.1c00417] [Reference Citation Analysis]
10 Tavares I, Costa-pereira JT, Martins I. Monoaminergic and Opioidergic Modulation of Brainstem Circuits: New Insights Into the Clinical Challenges of Pain Treatment? Front Pain Res 2021;2:696515. [DOI: 10.3389/fpain.2021.696515] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ebihara N, Ikemoto H, Adachi N, Okumo T, Kimura T, Yusa K, Hattori S, Manabe A, Hisamitsu T, Sunagawa M. Analgesic Effect of Combined Therapy with the Japanese Herbal Medicine "Yokukansan" and Electroacupuncture in Rats with Acute Inflammatory Pain. Medicines (Basel) 2021;8:31. [PMID: 34204458 DOI: 10.3390/medicines8060031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Bak MS, Park H, Kim SK. Neural Plasticity in the Brain during Neuropathic Pain. Biomedicines 2021;9:624. [PMID: 34072638 DOI: 10.3390/biomedicines9060624] [Reference Citation Analysis]
13 Moore L, Norwood C, Stackhouse R, Nguyen K, Brown W, Sevak RJ. Gabapentin reduces postoperative pain and opioid consumption in patients who underwent lumbar laminectomy. J Am Pharm Assoc (2003) 2021;61:e78-83. [PMID: 34024754 DOI: 10.1016/j.japh.2021.05.002] [Reference Citation Analysis]
14 Wang N, Zhang YH, Wang JY, Luo F. Current Understanding of the Involvement of the Insular Cortex in Neuropathic Pain: A Narrative Review. Int J Mol Sci 2021;22:2648. [PMID: 33808020 DOI: 10.3390/ijms22052648] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 He C, Wang X, Zhang J, Wang H, Zhao Y, Shah JN, Ma C, Li H, Su W, Zhang Z, Chen S, Zhou L, Dong S. MCRT, a multifunctional ligand of opioid and neuropeptide FF receptors, attenuates neuropathic pain in spared nerve injury model. Basic Clin Pharmacol Toxicol 2021;128:731-40. [PMID: 33533572 DOI: 10.1111/bcpt.13566] [Reference Citation Analysis]
16 Ahearn OC, Watson MN, Rawls SM. Chemokines, cytokines and substance use disorders. Drug Alcohol Depend 2021;220:108511. [PMID: 33465606 DOI: 10.1016/j.drugalcdep.2021.108511] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Glaros A, Brandow AM. Neuropathic pain in sickle cell disease: measurement and management. Hematology Am Soc Hematol Educ Program 2020;2020:553-61. [PMID: 33275730 DOI: 10.1182/hematology.2020000142] [Reference Citation Analysis]
18 Eisenstein TK, Chen X, Inan S, Meissler JJ, Tallarida CS, Geller EB, Rawls SM, Cowan A, Adler MW. Chemokine Receptor Antagonists in Combination with Morphine as a Novel Strategy for Opioid Dose Reduction in Pain Management. Mil Med 2020;185:130-5. [PMID: 32074321 DOI: 10.1093/milmed/usz320] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
19 Ferreira-Chamorro P, Redondo A, Riego G, Pol O. Treatment with 5-fluoro-2-oxindole Increases the Antinociceptive Effects of Morphine and Inhibits Neuropathic Pain. Cell Mol Neurobiol 2021;41:995-1008. [PMID: 32880099 DOI: 10.1007/s10571-020-00952-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
20 Speltz R, Lunzer MM, Shueb SS, Akgün E, Reed R, Kalyuzhny A, Portoghese PS, Simone DA. The bivalent ligand, MMG22, reduces neuropathic pain after nerve injury without the side effects of traditional opioids. Pain 2020;161:2041-57. [PMID: 32345918 DOI: 10.1097/j.pain.0000000000001902] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Kretzschmar M, Reining M, Schwarz MA. Three-Year Outcomes After Dorsal Root Ganglion Stimulation in the Treatment of Neuropathic Pain After Peripheral Nerve Injury of Upper and Lower Extremities. Neuromodulation 2021;24:700-7. [PMID: 32573868 DOI: 10.1111/ner.13222] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
22 Delery EC, Edwards S. Neuropeptide and cytokine regulation of pain in the context of substance use disorders. Neuropharmacology 2020;174:108153. [PMID: 32470337 DOI: 10.1016/j.neuropharm.2020.108153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Martínez-Navarro M, Cabañero D, Wawrzczak-Bargiela A, Robe A, Gavériaux-Ruff C, Kieffer BL, Przewlocki R, Baños JE, Maldonado R. Mu and delta opioid receptors play opposite nociceptive and behavioural roles on nerve-injured mice. Br J Pharmacol 2020;177:1187-205. [PMID: 31655493 DOI: 10.1111/bph.14911] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
24 Neyama H, Dozono N, Ueda H. NR2A-NMDA Receptor Blockade Reverses the Lack of Morphine Analgesia Without Affecting Chronic Pain Status in a Fibromyalgia-Like Mouse Model. J Pharmacol Exp Ther 2020;373:103-12. [DOI: 10.1124/jpet.119.262642] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
25 Yamaguchi M, Ishikawa M, Aono Y, Saigusa T. OX2 receptors mediate the inhibitory effects of orexin-A on potassium chloride-induced increases in intracellular calcium ion levels in neurons derived from rat dorsal root ganglion in a chronic pain model. Neuropsychopharmacol Rep 2020;40:30-8. [PMID: 31845549 DOI: 10.1002/npr2.12094] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Poli G, Dimmito MP, Mollica A, Zengin G, Benyhe S, Zador F, Stefanucci A. Discovery of Novel µ-Opioid Receptor Inverse Agonist from a Combinatorial Library of Tetrapeptides through Structure-Based Virtual Screening. Molecules 2019;24:E3872. [PMID: 31717871 DOI: 10.3390/molecules24213872] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
27 de la Puerta R, Carcelén M, Francés R, de la Fuente R, Hurlé MA, Tramullas M. BMP-7 protects male and female rodents against neuropathic pain induced by nerve injury through a mechanism mediated by endogenous opioids. Pharmacol Res 2019;150:104470. [PMID: 31590011 DOI: 10.1016/j.phrs.2019.104470] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]